NZ219516A - Fusion proteins of hbcag (hepatitis b virus core antigen) - Google Patents

Fusion proteins of hbcag (hepatitis b virus core antigen)

Info

Publication number
NZ219516A
NZ219516A NZ219516A NZ21951687A NZ219516A NZ 219516 A NZ219516 A NZ 219516A NZ 219516 A NZ219516 A NZ 219516A NZ 21951687 A NZ21951687 A NZ 21951687A NZ 219516 A NZ219516 A NZ 219516A
Authority
NZ
New Zealand
Prior art keywords
hbcag
hepatitis
fusion proteins
core antigen
virus core
Prior art date
Application number
NZ219516A
Inventor
Peter Edmund Highfield
Berwyn Ewart Clarke
Antony Robin Carroll
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NZ219516A publication Critical patent/NZ219516A/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
NZ219516A 1987-02-10 1987-03-05 Fusion proteins of hbcag (hepatitis b virus core antigen) NZ219516A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1294887A 1987-02-10 1987-02-10

Publications (1)

Publication Number Publication Date
NZ219516A true NZ219516A (en) 1991-02-26

Family

ID=21757520

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ219516A NZ219516A (en) 1987-02-10 1987-03-05 Fusion proteins of hbcag (hepatitis b virus core antigen)

Country Status (4)

Country Link
JP (1) JPS63196299A (en)
AU (2) AU596154B2 (en)
CA (1) CA1319628C (en)
NZ (1) NZ219516A (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ235315A (en) * 1989-09-19 1991-09-25 Wellcome Found Chimaeric hepadnavirus core antigen proteins and their construction
SE468050C (en) * 1991-03-15 1998-02-11 Pharmacia & Upjohn Ab Recombinant human factor VIII derivative
RU2212899C2 (en) * 1991-09-13 2003-09-27 Чирон Корпорейшн Hcv-immunoreactive polypeptide compositions
JP5132851B2 (en) * 1997-08-05 2013-01-30 フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー（ヴェーイーベー・ヴェーゼットウェー） New immunoprotective influenza antigens and their use in vaccination
US7731972B1 (en) 2000-02-04 2010-06-08 Vlaams Interuniversitair Instituut Voor Biotechnologie Immunoprotective influenza antigen and its use in vaccination
CA2594612A1 (en) 2005-01-19 2006-07-27 Vaxinnate Corporation Compositions comprising pathogen-associated molecular patterns and antigens and their use to stimulate an immune response
TW200745158A (en) 2006-03-07 2007-12-16 Vaxinnate Corp Compositions that include hemagglutinin, methods of making and methods of use thereof
AU2009236585B2 (en) 2008-04-18 2013-03-07 Vaxinnate Corporation Deletion mutants of flagellin and methods of use
WO2010074126A1 (en) * 2008-12-25 2010-07-01 財団法人化学及血清療法研究所 Recombinant avian-infectious coryza vaccine and method for producing same
US8932598B2 (en) 2012-08-28 2015-01-13 Vaxinnate Corporation Fusion proteins and methods of use
AU2016313660B2 (en) * 2015-08-25 2019-11-07 Xiamen University Polypeptide carrier for presenting target polypeptide and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW18282A1 (en) * 1981-08-31 1983-03-23 Genentech Inc Preparation of polypeptides in vertebrate cell culture
IE56716B1 (en) * 1983-01-19 1991-11-20 Genentech Inc Method for producing human tpa and expression vectors therefor
EP0175261B1 (en) * 1984-09-12 1991-12-11 Chiron Corporation Hybrid particle immunogens
JPS6274295A (en) * 1985-09-25 1987-04-06 チロン　コ−ポレイシヨン Hybrid granular immunogen
NZ219515A (en) * 1987-02-10 1989-09-27 Wellcome Found Fusion proteins comprising influenza virus ha and a nonnatural antigenic epitope

Also Published As

Publication number Publication date
AU6979287A (en) 1988-08-11
AU642859B2 (en) 1993-11-04
CA1319628C (en) 1993-06-29
AU596154B2 (en) 1990-04-26
AU4927390A (en) 1990-08-09
JPS63196299A (en) 1988-08-15

Similar Documents

Publication Publication Date Title
PT86640A (en) HEPATITIS B VIRUS SURFACE ANTIGENS AND HYBRID ANTIGENS CONTAINING THEM
HK38293A (en) Hepatitis c virus
DK643387A (en) T-CELL EPITOPES OF HEPATITIS B VIRUS NUCLEOCAPSIDE PROTEIN
GB2212511B (en) Hepatitis c virus
PH25249A (en) Method for producing hepatitis b virus proteins in yeast
NZ219516A (en) Fusion proteins of hbcag (hepatitis b virus core antigen)
PT85137A (en) T and b cell epitopes of the pre-s region of hepatitis b virus surface antigen
AU5223990A (en) Monoclonal antibodies to Pres2 and Pres1 polypeptides of the hepatitis B viral envelope
ZA894182B (en) Method for producing nonhyperglycosylated hepatitis b virus proteins
DK610587A (en) METHOD AND METHOD OF ANY ANTIBODY FOR HEPATITIS B CORE ANTIGEN
IL85811A0 (en) Assay for detecting hepatitis antigens and aids antibodies
EP0503950A3 (en) Method of purifying recombinant hepatitis b virus surface proteins from recombinant cells
AU7648191A (en) Monoclonal antibodies to pres2 and pres1 polypeptides of the hepatitis b viral envelope
KR890701743A (en) Hepatitis B surface antigen vaccine
AU1668788A (en) Method of vaccination for hepatitis b virus
GB2181434A (en) Hepatitis b virus vaccine and process for its preparation
GB8622883D0 (en) Expression of hepatitis b viral antigens
EP0503252A3 (en) Recombinant proteins having the immunoreactivity of hepatitis b virus e antigens (hbeag), method for their production and their application in immunoassays and as vaccines
IE891804L (en) Nonhyperglycosylated hepatitis b virus proteins
IE891315L (en) Expression of hepatitis b. pres2 protein in methylotrophic¹yeasts
GB8621578D0 (en) Hepatitis b viral antigens
CS627787A1 (en) Mouse lymphocytar hybridome producing antibodies against antigen of b-hepatitis virus (hbeag)
IE852110L (en) Recombinant hepatitis antigen
JPS645492A (en) Production of b type hepatitis virus protein in yeast
NZ215820A (en) Hepatitis b antigen formed by recombinant dna techniques